Atomwise patented the first deep learning technology for structure-based small molecule drug discovery. This AI technology harnesses millions of data points and thousands of protein structures to solve problems that a human chemist would take many lifetimes to solve. They've partnered with some of the world’s largest pharmaceutical and agrochemical companies, and with more than 50 leading academic institutions and hospitals, to tackle the challenges of discovering and developing better drugs and chemicals. 

Biotechnology

Atomwise

Gavin Hirst

Wenhu Huang

Matthew Merkley

Mallorie Lynch

Ed Kawashiri

Robert Mittendorff

Izhar Wallach

Denzil Bernard

Yan Zhao

Nicole Dishotsky

The Drug Discovery and Medicinal Chemistry team at Atomwise utilizes advanced AI-driven technologies to design and discover novel small molecule drugs. By analyzing vast datasets and protein structures, they collaboratively work on optimizing molecular properties, predicting drug interactions, and accelerating the development of effective therapeutic candidates. The team consists of experts in medicinal chemistry, computational chemistry, cheminformatics, and biology, all focused on transforming the landscape of drug discovery through innovative approaches and strategic partnerships.

Drug Discovery and Medicinal Chemistry

Leadership Team

Directors Team

Drug Discovery and Medicinal Chemistry

About

Team members

Other teams at Atomwise

Leadership Team

Directors Team